Clinical Trial Update: An Observational Study to Evaluate Cardiovascular Outcomes of T2DM PatientsTreated With Gemigliptin

View source ↗

Summary

An observational study evaluating cardiovascular outcomes in type 2 diabetes patients treated with gemigliptin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Gemigliptin (gemigliptin)

Snippet

Sponsor: LG Life Sciences | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED